Ali Mumtaz
Foot & Ankle Surgery · Pasadena, MDNPI 1508217993
Payments from drug & device makers
Across 32 payments — averaging $152.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$4K
- Organogenesis Inc.$239
- Smith+Nephew$153
- Stryker$136
- Baxter Healthcare$105
- Melinta Therapeutics, LLC$67
- plus $277 from 11 others
What the payments were for
- Food & beverage$99020%
- Education$3,88780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 4 | $3,900 |
| Organogenesis Inc. | 4 | $239 |
| Smith+Nephew | 4 | $153 |
| Stryker | 1 | $136 |
| Baxter Healthcare | 4 | $105 |
| Melinta Therapeutics, LLC | 1 | $67 |
| Nevro Corp. | 2 | $41 |
| Tactile Systems Technology Inc | 2 | $30 |
| Bioventus LLC | 2 | $30 |
| Linvatec Corporation | 1 | $28 |
| Zimmer Biomet | 1 | $27 |
| Globus Medical | 1 | $25 |
| AbbVie | 1 | $25 |
| Vertex | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALLOGRAFT$136
- SONICANCHOR$136
- FIXOS$136
- Puraply Antimicrobial$124
- COLLAGENASE SANTYL$118
How this compares
$4,877 in reported general payments places this provider in the 65th percentile of 182 foot & ankle surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 113 | $2,560 |
| Ammonium Lactate | 86 | $1,773 |
| Ciclopirox | 48 | $1,067 |
| Diclofenac Sodium | 25 | $1,046 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 52 | $1,029 |
| Silver Sulfadiazine | 18 | $137 |
| Mupirocin | 17 | $125 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Pasadena
- Donald HarrisonPasadena$112K
- Lew SchonBaltimore$782K
- Stuart MillerBaltimore$624K
- Mark SpierGlen Burnie$400K
- Jeffrey BrodieTowson$366K
- Patrick MaloneyBaltimore$280K
- Gregory GuytonBaltimore$217K
- Walter HembreeBaltimore$166K
- Clifford JengBaltimore$157K
- Hummira AbawiColumbia$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.